Modafinil | Placebo | Entire group | |
---|---|---|---|
(n = 20) | (n = 20) | (n = 40) | |
*Data are mean (SD). | |||
UPDRS, Unified Parkinson’s Disease Rating Scale. | |||
Age (years)* | 64.4 (10.4) | 65.1 (12.3) | 64.8 (11.3) |
Sex (men/women) | 13/7 | 13/7 | 29/11 |
Duration of Parkinson’s disease* | 6.5 (5.5) | 7.0 (4.6) | 6.8 (5.0) |
Dopaminergic dose(mg/day)* | 7.3 (3.5) | 9.5 (5.2) | 8.5 (4.6) |
Fluctuating response | 5/20 | 7/20 | 12/40 |
UPDRS activities of daily living* | 12.9 (5.5) | 14.4 (6.0) | 13.7 (5.8) |
UPDRS motor* | 24.1 (9.8) | 29.2 (9.5) | 26.7 (9.8) |
Epworth score* | 15.8 (3.0) | 15.9 (3.5) | 15.8 (3.2) |